Seller record · Telehealth service
Rixa Health
Fails 1 of 8 criteria. S5, analytical documentation: No certificate of analysis or lot document is published on the weight-loss, pricing or partner pharmacies pages or in the terms.
At a glance
Rixa HealthTelehealth service
- Price
- Semaglutide from $195 every 4 weeks, tirzepatide from $280
- Sells
- compounded semaglutide injection, compounded tirzepatide injection, and 3 more
- FDA letters
- None on file
Telehealth service. Passes 7 of 8 criteria. Recorded against Standard v1.1.
An Ohio telehealth practice run by named osteopathic physicians and a nurse practitioner, selling compounded semaglutide and tirzepatide injections and dissolving tablets, including a weight-loss program for teens aged 16 to 18, with hormone care and peptide therapy priced at the visit. It names two partner pharmacies.
Operating entity No legal entity name appears in the footer, on the contact page, in the terms or in the privacy policy, which refer only to the owner and the brand name.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Rixa Health's website; Rixa Health's about page; Rixa Health's medical weight loss page |
| S2 | Prescription gating | PASS | Rixa Health's website |
| S3 | Pharmacy identification | PASS | Rixa Health's partner pharmacies page |
| S4 | Compounding disclosure | PASS | Rixa Health's medical weight loss page |
| S5 | Analytical documentation | FAIL | Rixa Health's medical weight loss page; Rixa Health's pricing page; Rixa Health's partner pharmacies page |
| S6 | Business address | PASS | Rixa Health's contact page |
| S7 | Price disclosure | PASS | Rixa Health's pricing page; Rixa Health's medical weight loss page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, compounded tirzepatide injection, semaglutide with B12 oral dissolving tablets, tirzepatide oral dissolving tablets, peptide therapy.
Other sellers of the same products
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.